drugset
drugset / Trial / NCT05866536

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

NCT05866536 ↗

Phase 2 Active not recruiting 100 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate if repeat bacillus Calmette-Guérin (BCG) vaccinations can confer a beneficial immune and metabolic effect in new onset pediatric Type 1 diabetes.

Timeline

Start
2023-05-04
Primary completion
2031-05
Completion
2031-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus Calmette-Guérin Vaccine — —

Indications

type 1 diabetes mellitus